Statistics for Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC
Total visits
views | |
---|---|
Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC | 2 |
Total visits per month
views | |
---|---|
January 2024 | 0 |
February 2024 | 0 |
March 2024 | 0 |
April 2024 | 0 |
May 2024 | 2 |
June 2024 | 0 |
July 2024 | 0 |
Top country views
views | |
---|---|
United States | 2 |
Top city views
views | |
---|---|
Franklin | 2 |